← Search & browse all drugs
CARDIOVASCULAR SYSTEM › VASOPROTECTIVES › AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE › Other agents for treatment of hemorrhoids and anal fissures for topical use
bismuth preparations, combinations
C05AX02
Forms & Strengths
- Suppositories: Bismuth subgallate 200 mg / bismuth subgallate combinations
- Topical Ointment/Cream: Bismuth subgallate combined with zinc oxide, balsam of Peru, and hydrocortisone
Adult Dosing
- Rectal suppositories: Insert 1 suppository rectally twice daily (morning and evening) and after each bowel movement
- Topical ointment: Apply a thin layer to the affected perianal area up to 3 to 4 times daily
Pediatric Dosing
- Safety and efficacy in pediatric patients have not been established; use is generally not recommended
Indications
- Symptomatic relief of anorectal disorders, hemorrhoids, and perianal inflammation
- Temporary relief of burning, itching, and discomfort associated with hemorrhoids
Mechanism of Action
- Bismuth subgallate acts as an astringent by precipitating proteins on broken skin and mucous membranes
- Provides a protective physical coating over inflamed anorectal tissue to reduce irritation
- Exhibits mild antiseptic and vasoconstrictive properties to reduce local edema and weeping
Contraindications
- Hypersensitivity to bismuth preparations or any component of the formulation
- Presence of anorectal tuberculosis, fungal infections, or viral lesions (e.g., herpes simplex) in the application area
Adverse Reactions
- Local burning, stinging, or irritation at the application site
- Contact dermatitis or allergic skin reactions due to excipients or active ingredients
- Rare systemic absorption leading to bismuth toxicity with prolonged or extensive use on broken skin
Drug Interactions
- Concurrent use of multiple topical anorectal products may increase the risk of skin irritation
- Potential decreased absorption of other rectally administered medications due to the protective mucosal barrier
Curated Content: Needs Vetting Before Put to Clinical Use